Anixa Biosciences…announced that the Chinese National Intellectual Property Administration (CNIPA) has issued Patent Number ZL2020800215666, covering key aspects of the Company&#39;s breast cancer vaccine technology

alpha-lactalbumin vaccine - Anixa Biosci, Cleveland Clinic

Oct 20, 2025